The collaboration aims to tackle AMR in India by focusing on tier 2 and tier 3 cities, bridging the gap between awareness and action, and ensuring sustainable AMR interventions
The Earnings before interest, tax, depreciation, and amortisation (Ebitda) for the second quarter stood at Rs 30 crore as compared to Rs 24 crore a year ago which implies a rise of 25 per cent
Shares of Orchid Pharma soared up to 7.69 per cent, hitting its 52-week high at Rs 1,591.55 per share on the BSE in Tuesday's early morning deals
The rise came following Orchid Pharma's announcement of a collaboration with pharmaceutical giant Cipla to introduce the antibiotic Cefepime-Enmetazobactam in India